SCORTEN scale
SCORTEN Scale is a medical tool used to predict the mortality of patients with Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). It was developed by Bastuji-Garin et al. in 2000 and has since been validated in multiple studies.
Overview[edit]
The SCORTEN scale, also known as the Severity-of-Illness Score for Toxic Epidermal Necrolysis, is a scoring system that uses seven independent risk factors to predict the mortality of patients with SJS and TEN. Each risk factor is assigned one point, and the total score is used to predict the patient's risk of death.
Risk Factors[edit]
The seven risk factors included in the SCORTEN scale are:
- Age > 40 years
- Presence of a malignancy
- Heart rate > 120 bpm
- Initial body surface area of epidermal detachment > 10%
- Serum urea level > 28 mg/dL
- Serum glucose level > 252 mg/dL
- Serum bicarbonate level < 20 mEq/L
Scoring and Mortality Prediction[edit]
The total SCORTEN score is calculated by adding up the points for each risk factor present. The predicted mortality rates based on the SCORTEN score are as follows:
- Score 0-1: 3.2% mortality
- Score 2: 12.1% mortality
- Score 3: 35.3% mortality
- Score 4: 58.3% mortality
- Score 5: 90% mortality
Limitations[edit]
While the SCORTEN scale is a useful tool for predicting mortality in SJS and TEN patients, it does have some limitations. It does not take into account the patient's response to treatment, and it may not be accurate in all populations.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
